Search Results
Search for other papers by Hyunjae Lee in
Google Scholar
PubMed
Search for other papers by Tae-Shin Kim in
Google Scholar
PubMed
Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
Search for other papers by Ja-Yoon Gu in
Google Scholar
PubMed
Search for other papers by Mi Ran Yu in
Google Scholar
PubMed
Search for other papers by Seung-Eun Lee in
Google Scholar
PubMed
Search for other papers by Eun Sook Kim in
Google Scholar
PubMed
Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
Search for other papers by Hyun Kyung Kim in
Google Scholar
PubMed
Introduction Differentiated thyroid cancer (DTC) is the most commonly diagnosed endocrine malignancy ( 1 ) and the risk of its recurrence varies from patient to patient, ranging from less than 5% to more than 20% ( 2 ). Efforts have been made
Structural and Functional Biology Program, Universidade Federal de São Paulo, São Paulo, Brazil
Search for other papers by Erika Urbano Lima in
Google Scholar
PubMed
Structural and Functional Biology Program, Universidade Federal de São Paulo, São Paulo, Brazil
Search for other papers by Ileana G S Rubio in
Google Scholar
PubMed
Post-graduate Program in Interactive Processes of Organs and Systems, Health & Science Institute, Federal University of Bahia, Salvador, Brazil
Search for other papers by Joaquim Custodio Da Silva in
Google Scholar
PubMed
Search for other papers by Ana Luiza Galrão in
Google Scholar
PubMed
Post-graduate Program in Interactive Processes of Organs and Systems, Health & Science Institute, Federal University of Bahia, Salvador, Brazil
Search for other papers by Danielle Pêssoa in
Google Scholar
PubMed
Search for other papers by Taise Cerqueira Oliveira in
Google Scholar
PubMed
Post-graduate Program in Interactive Processes of Organs and Systems, Health & Science Institute, Federal University of Bahia, Salvador, Brazil
Search for other papers by Fabiane Carrijo in
Google Scholar
PubMed
Search for other papers by Igor Silva Campos in
Google Scholar
PubMed
Department of Anatomic Pathology & Legal Medicine, Bahia Federal Medical School, Federal University of Bahia, Salvador, Brazil
Search for other papers by Luciano Fonseca Espinheira in
Google Scholar
PubMed
Search for other papers by Luiz Jose Sampaio in
Google Scholar
PubMed
Search for other papers by Claudio Rogerio Lima in
Google Scholar
PubMed
Division of Genetics, Department of Morphology and Genetics, Genetic Basis of Thyroid Tumors Laboratory, Paulista School of Medicine, Universidade Federal de São Paulo, São Paulo, Brazil
Search for other papers by Janete Maria Cerutti in
Google Scholar
PubMed
Post-graduate Program in Interactive Processes of Organs and Systems, Health & Science Institute, Federal University of Bahia, Salvador, Brazil
Search for other papers by Helton Estrela Ramos in
Google Scholar
PubMed
Introduction Differentiated thyroid cancer (DTC) has continued to increase over the past several decades, likely due to enhanced detection ( 1 , 2 ). Cancer research, in general, has benefited greatly from many of the new scientific
Search for other papers by Eugenie S Lim in
Google Scholar
PubMed
Search for other papers by Shanty G Shah in
Google Scholar
PubMed
Search for other papers by Mona Waterhouse in
Google Scholar
PubMed
Barts and the London School of Medicine and Dentistry, QMUL, London, UK
Search for other papers by Scott Akker in
Google Scholar
PubMed
Barts and the London School of Medicine and Dentistry, QMUL, London, UK
Search for other papers by William Drake in
Google Scholar
PubMed
Barts and the London School of Medicine and Dentistry, QMUL, London, UK
Search for other papers by Nick Plowman in
Google Scholar
PubMed
Barts and the London School of Medicine and Dentistry, QMUL, London, UK
Search for other papers by Daniel M Berney in
Google Scholar
PubMed
Search for other papers by Polly Richards in
Google Scholar
PubMed
Search for other papers by Ashok Adams in
Google Scholar
PubMed
Search for other papers by Ewa Nowosinska in
Google Scholar
PubMed
Search for other papers by Carmel Brennan in
Google Scholar
PubMed
Barts and the London School of Medicine and Dentistry, QMUL, London, UK
Search for other papers by Maralyn Druce in
Google Scholar
PubMed
Introduction Differentiated thyroid cancer (DTC) is the most frequently occurring endocrine cancer and its incidence has been increasing steadily in men and women over the last few decades ( 1 , 2 , 3 ). DTC includes papillary thyroid cancer
Clinic for Nuclear Medicine, University Hospital of Zürich, Zürich, Switzerland
Search for other papers by Luca Giovanella in
Google Scholar
PubMed
Search for other papers by Maria Luisa Garo in
Google Scholar
PubMed
Search for other papers by Domenico Albano in
Google Scholar
PubMed
Search for other papers by Rainer Görges in
Google Scholar
PubMed
Faculty of Biomedical Sciences, Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland
Search for other papers by Luca Ceriani in
Google Scholar
PubMed
. References 1 Avram AM Zukotynski K Nadel HR Giovanella LM . Management of differentiated thyroid cancer: the standard of care . Journal of Nuclear Medicine 2022 63 189 – 195 . ( https://doi.org/10.2967/jnumed.121.262402 ) 2 Giovanella L
Search for other papers by Jiaxin Luo in
Google Scholar
PubMed
Search for other papers by Weili Yin in
Google Scholar
PubMed
Search for other papers by Qiuxia Lin in
Google Scholar
PubMed
Search for other papers by Juqing Wu in
Google Scholar
PubMed
Search for other papers by Pan Chen in
Google Scholar
PubMed
Search for other papers by Yuanna Ling in
Google Scholar
PubMed
Search for other papers by Jing Wang in
Google Scholar
PubMed
Search for other papers by Zhen Li in
Google Scholar
PubMed
Search for other papers by Liqin Pan in
Google Scholar
PubMed
Search for other papers by Yanying Chen in
Google Scholar
PubMed
Search for other papers by Wei Ouyang in
Google Scholar
PubMed
Search for other papers by Huijuan Feng in
Google Scholar
PubMed
Introduction Bone metastasis is the second most common type of distant metastasis in differentiated thyroid cancer (DTC) after lung metastasis, with an incidence of 2–13%, strongly suggesting a poor prognosis ( 1 , 2 , 3 , 4 , 5 , 6
Search for other papers by Natalie Su-Jing Yap in
Google Scholar
PubMed
Search for other papers by Richard Maher in
Google Scholar
PubMed
Departments of Endocrinology, Radiology, Sydney Medical School, Royal North Shore Hospital, St Leonards, New South Wales, Australia
Search for other papers by Diana Louise Learoyd in
Google Scholar
PubMed
-needle aspirates of cervical lymph nodes: a technique for the diagnosis of metastatic differentiated thyroid cancer . European Journal of Endocrinology 2007 157 101 – 107 . ( doi:10.1530/EJE-07-0088 ). 5 Boi F Baghino G Atzeni F Lai ML Faa G
Search for other papers by C Sui in
Google Scholar
PubMed
Search for other papers by Q He in
Google Scholar
PubMed
Search for other papers by R Du in
Google Scholar
PubMed
Search for other papers by D Zhang in
Google Scholar
PubMed
Search for other papers by F Li in
Google Scholar
PubMed
Search for other papers by G Dionigi in
Google Scholar
PubMed
Search for other papers by N Liang in
Google Scholar
PubMed
Search for other papers by H Sun in
Google Scholar
PubMed
dissected cervical nodes, however, a discrepancy may exist between the absolute number of positive nodes and the substantive extent of differentiated thyroid cancer (DTC) node metastasis ( 1 , 2 , 6 ). Therefore, the NR, defined as the absolute number of
Division of General Medicine, Istituto Auxologico Italiano, IRCCS, S. Giuseppe Hospital, Piancavallo di Oggebbio (VB), Italy
Search for other papers by Chiara Mele in
Google Scholar
PubMed
Search for other papers by Maria Teresa Samà in
Google Scholar
PubMed
Search for other papers by Alessandro Angelo Bisoffi in
Google Scholar
PubMed
Search for other papers by Marina Caputo in
Google Scholar
PubMed
Search for other papers by Valentina Bullara in
Google Scholar
PubMed
Search for other papers by Stefania Mai in
Google Scholar
PubMed
Search for other papers by Gillian Elisabeth Walker in
Google Scholar
PubMed
Search for other papers by Flavia Prodam in
Google Scholar
PubMed
Division of General Medicine, Istituto Auxologico Italiano, IRCCS, S. Giuseppe Hospital, Piancavallo di Oggebbio (VB), Italy
Search for other papers by Paolo Marzullo in
Google Scholar
PubMed
Search for other papers by Gianluca Aimaretti in
Google Scholar
PubMed
Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy
Search for other papers by Loredana Pagano in
Google Scholar
PubMed
Introduction The incidence rates of differentiated thyroid cancer (DTC) have been rising in many countries over the last few decades ( 1 , 2 ) along with a parallel increase in obesity and metabolic disorders ( 3 ). Even if the growing
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Trynke van der Boom in
Google Scholar
PubMed
Search for other papers by Wouter T Zandee in
Google Scholar
PubMed
Search for other papers by Joop D Lefrandt in
Google Scholar
PubMed
, sinus tachycardia, and diastolic dysfunction ( 15 ). TSH suppression in differentiated thyroid cancer Adults Differentiated thyroid cancer, consisting of papillary and follicular thyroid cancer, is common at a relatively young age, with a
Search for other papers by Keiko Ohkuwa in
Google Scholar
PubMed
Search for other papers by Kiminori Sugino in
Google Scholar
PubMed
Search for other papers by Mitsuji Nagahama in
Google Scholar
PubMed
Search for other papers by Wataru Kitagawa in
Google Scholar
PubMed
Search for other papers by Kenichi Matsuzu in
Google Scholar
PubMed
Search for other papers by Akifumi Suzuki in
Google Scholar
PubMed
Search for other papers by Chisato Tomoda in
Google Scholar
PubMed
Search for other papers by Kiyomi Hames in
Google Scholar
PubMed
Search for other papers by Junko Akaishi in
Google Scholar
PubMed
Search for other papers by Chie Masaki in
Google Scholar
PubMed
Search for other papers by Koichi Ito in
Google Scholar
PubMed
Introduction The incidence of thyroid cancer has increased over the previous decade. The 5- and 10-year relative survival rates for patients with differentiated thyroid cancer (DTC) are 90–95% ( 1 , 2 ). Distant metastasis occurs in 5–20% of